drugset / Trial / NCT01953679
Efficacy Study of Two Continuous Regimens of Oral Daily 5 mg or 10 mg of Ulipristal Acetate (UPA), Versus a Dose of 5.0mg UPA for 24/4 Days
Phase 2
Completed
180 enrolled
Premier Research
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · collab
RandomizedParallel-groupTriple-blindPrevention
Summary
To compare the pharmacodynamic effects of 2 continuous dose regimens of ulipristal acetate 5.0 and 10.0 mg-only oral contraception, versus a 24/4 day regimen of UPA 5.0 mg.
Timeline
- Start
- 2014-03
- Primary completion
- 2015-08
- Completion
- 2015-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ulipristal Acetate | Unknown | 5 mg | Oral |
| Comparator | Ulipristal Acetate | Unknown | 10 mg | Oral |
Indications
No indication recorded.